|1.||Shirai, Takashi: 2 articles (05/2015 - 01/2014)|
|2.||Furukawa, Kiyoshi: 2 articles (05/2015 - 01/2014)|
|3.||Hirano, Kiyoko: 2 articles (05/2015 - 01/2014)|
|4.||Matsuda, Akio: 2 articles (05/2015 - 01/2014)|
|5.||Kuji, Ryo: 1 article (05/2015)|
|6.||Nakandakari, Shiro: 1 article (05/2015)|
|7.||Kaneko, Tomonori: 1 article (02/2015)|
|8.||Ide, Youichi: 1 article (02/2015)|
|9.||Ishida, Kenji: 1 article (02/2015)|
|10.||Suda, Yoshihiko: 1 article (02/2015)|
05/22/2015 - "We found that the expression level of the LacdiNAc group decreases as human breast cancers progress. "
01/01/2014 - "The mechanism of formation of the LacdiNAc group in human tumors and cancer cells has been studied, and two β 4-N-acetylgalacto-saminyltransferases ( β 4GalNAcTs), β 4GalNAcT3 and β 4GalNAcT4, have been shown to be involved in the biosynthesis of this disaccharide group in a tissue-dependent manner. "
01/01/2014 - "Expression of LacdiNAc groups on N-glycans among human tumors is complex."
08/01/2012 - "Analysis of the released O-linked oligosaccharides by LC-MS from these individuals showed a very heterogeneous mixture of species from the cancer patient containing both neutral and sialylated structures, whereas the normal sample showed dominating neutral blood group H terminating structures as well as neutral structures containing the di-N-acetyllactosamine (lacdiNAc) unit GalNAcβ1-4GlcNAcβ1- on the C-6 branch of the reducing end GalNAc. "
03/01/2011 - "It also establishes the basis to further explore high-mannose-type glycans, and the LacdiNAc motif as possible markers of ovarian carcinoma."
02/01/2013 - "Based on these ions, which can also be produced by nanoESI-MS(n), we demonstrated that the glycome of an ovarian carcinoma cell line, RMG-1, comprises a high abundance of sulfated lacdiNAc epitopes carried on multiantennary complex type N-glycans alongside fucosylated, sialylated and/or sulfated lacNAc antennae. "
|3.||Breast Neoplasms (Breast Cancer)
11/07/2014 - "Similarly, other glycan features were found to be altered in breast cancer secretomes including paucimannose and complex type N-glycans containing bisecting β1,4-GlcNAc and LacdiNAc determinants. "
01/01/2014 - "We previously showed that the expression level of the LacdiNAc group in N-glycans decreases dramatically during the progression of human breast cancer. "
|4.||Colorectal Neoplasms (Colorectal Cancer)
|5.||Prostatic Neoplasms (Prostate Cancer)
02/03/2015 - "A high-sensitivity immunoassay system with surface plasmon field-enhanced fluorescence spectrometry (SPFS) was constructed using a plastic sensor chip and then applied to the detection of total prostate-specific antigen (total PSA) and GalNAcβ1-4GlcNAc-linked prostate-specific antigen (LacdiNAc-PSA) in serum, to discriminate between prostate cancer (PC) and benign prostate hyperplasia (BPH). "
|2.||Prostate-Specific Antigen (Semenogelase)
|9.||ABO Blood-Group System